医疗数据解决方案提供商OneMedNet近日与神经科技公司Risorius达成战略合作协议，双方将围绕脑电图（EEG）数据展开深度合作，共同加速数字生物标记物的开发进程。此次合作将整合OneMedNet的医疗数据管理平台与Risorius的神经信号分析技术，旨在通过脑电图数据挖掘为神经系统疾病诊断提供创新解决方案。
该合作计划聚焦于帕金森病、阿尔茨海默病等神经退行性疾病的早期筛查领域。通过分析大规模脑电图数据集，研究团队将探索与疾病进展相关的数字化特征，推动精准医疗在神经科学领域的应用突破。业内观察人士指出，这种跨领域数据协作模式有望为生物标记物开发带来新的技术路径。
值得注意的是，此次合作将采用人工智能算法对多维度神经信号进行模式识别，重点开发具有临床验证价值的动态生物标记物。双方技术团队表示，这种基于真实世界数据的研究方法，能够显著提升数字诊断工具的可推广性和适应性。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.